Tirzepatide
A dual-action peptide that targets two hormone pathways for powerful weight management and blood sugar control.
This peptide is an FDA-approved drug product that can be legally prescribed by licensed clinicians.
The basics
- Generic Name
- tirzepatide
- Brand Names
- Mounjaro, Zepbound
- Regulatory Status
- Prescribed by Doctors
- Therapeutic Areas
- Metabolic & Weight Management
- Prescribing Specialties
- Primary care, Endocrinology, Obesity medicine, Sleep medicine
Wellness Goals
What it does
Tirzepatide is an FDA-approved medication that your doctor can prescribe. Dual GIP and GLP-1 receptor agonist that activates both incretin pathways, improving insulin sensitivity, glucagon regulation, and satiety signaling.
How it's taken
Weekly subcutaneous injection
How people access it
Prescribed by any licensed doctor and filled at a retail pharmacy. Available as Mounjaro (diabetes) or Zepbound (weight management). Insurance coverage varies by indication.
What doctors prescribe it for
- Type 2 diabetes mellitus (Mounjaro)
- Chronic weight management in adults with obesity (Zepbound)
- Obstructive sleep apnea in adults with obesity (Zepbound)
Clinicians may prescribe FDA-approved drugs for off-label uses based on their clinical judgment. Off-label indications have not undergone the same FDA review process as the labeled uses listed above.
How to know it's legit
You can independently verify the FDA-approval status of Tirzepatide through these free, publicly available databases:
- DailyMed (dailymed.nlm.nih.gov) — Search for Mounjaro to find the current FDA-approved labeling, including indications, dosing, warnings, and contraindications.
- Drugs@FDA (accessdata.fda.gov/scripts/cder/daf/) — Search to find the original approval letter, review documents, and approval history.
- FDA Orange Book (orangebook.fda.gov) — Search for therapeutic equivalence evaluations and patent/exclusivity information.
Common Questions
Mounjaro and Zepbound both contain tirzepatide as the active ingredient. Mounjaro is FDA-approved for type 2 diabetes mellitus, while Zepbound is FDA-approved for chronic weight management in adults with obesity or overweight with weight-related conditions. The dosing and administration are similar, but they are prescribed for different indications.
Compounding of tirzepatide is a complex legal and regulatory area. FDA has taken enforcement actions against certain compounders. Compounded drugs are not FDA-approved and do not undergo the same manufacturing and quality testing as approved products. The legal status may change as FDA continues to evaluate shortage designations and compounding eligibility.
Legitimate tirzepatide comes from a licensed pharmacy with a valid prescription from a licensed clinician. FDA-approved tirzepatide (Mounjaro, Zepbound) is manufactured by Eli Lilly. You can verify a pharmacy through your state board of pharmacy and check product information on DailyMed (dailymed.nlm.nih.gov).
Want to learn more?
Explore how Tirzepatide compares to other options, or dive deeper into how FDA approval works.
Explore All Peptides